Adverse effects Local or systemic inflammatory response, cardiovascular abnormalities, and thromboembolic complications · patients with Buerger's disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Health‐related quality of life · DCM (non‐ischaemic)
1 finding from 1 review
Performance status – functional class (NYHA) · DCM (non‐ischaemic)
1 finding from 1 review
Functional capacityAssessed: 6MWT · DCM (non‐ischaemic)
1 finding from 1 review
MACE · DCM (non‐ischaemic)
1 finding from 1 review
All‐cause mortality · DCM (non‐ischaemic)
It is very uncertain whether stem cell therapy (any type) changes all‐cause mortality compared with peripheral therapy with granulocyte colony‐stimulating factor (very low certainty).
1 finding from 1 review
Procedural complications · DCM (non‐ischaemic)
1 finding from 1 review
All‐cause mortality · DCM (non‐ischaemic)
It is very uncertain whether stem cell therapy changes all‐cause mortality compared with control (very low certainty).
1 finding from 1 review
Procedural complications · DCM (non‐ischaemic)
1 finding from 1 review
Health‐related quality of life · DCM (non‐ischaemic)
1 finding from 1 review
Functional capacityAssessed: 6MWT · DCM (non‐ischaemic)
1 finding from 1 review
Performance status – change in functional class (NYHA) · DCM (non‐ischaemic)
1 finding from 1 review
MACE · DCM (non‐ischaemic)
1 finding from 1 review
Ventricular arrhythmias (within 30 days) · DCM (non‐ischaemic)
1 finding from 1 review
Rate of amputation · patients with Buerger's disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Ulcer healing · patients with Buerger's disease
1 finding from 1 review
Pain Measured using a validated pain score or scale, or quality of life questionnaire · patients with Buerger's disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
30‐Day amputation‐free survival · patients with Buerger's disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Pain‐free walking distance · patients with Buerger's disease
1 finding from 1 review
Overall survival at 5‐year · women with early poor prognosis breast cancer
High‐dose chemotherapy showed no clear difference in overall survival at 5‐year compared with chemotherapy without bone marrow transplant or stem cell rescue (high certainty).
1 finding from 1 review